Doris K Hansen

34PUBLICATIONS

153CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (34)

Sort by Publication Date:

|Jul 08, 2026

Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.

|Jul 02, 2026

Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.

|Jun 20, 2026

Expanded antigen-specific donor regulatory T cells for GVHD prevention.

|Jun 16, 2026

Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.

|Jun 11, 2026

Product-Intrinsic NF-κB-Driven Transcriptional Programs Connote Durability of CAR-T Response in Multiple Myeloma.

|Jun 03, 2026

Targeting BCMA in patients with relapsed/refractory multiple myeloma in 1 to 3 prior lines of therapy.

Pageof 6

Frequent Collaborators

18 joint publications

Surbhi Sidana

18 joint publications

Omar Castaneda Puglianini

16 joint publications

Jack Khouri

15 joint publications

James A Davis

14 joint publications

Larry D Anderson

14 joint publications

Krina Patel

13 joint publications

Rahul Banerjee

12 joint publications

Danai Dima

12 joint publications

Aimaz Afrough

11 joint publications

Douglas W Sborov

Frequent Collaborators

18 joint publications

Surbhi Sidana

18 joint publications

Omar Castaneda Puglianini

16 joint publications

Jack Khouri

15 joint publications

James A Davis